Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy
    • Pharmaceutical...

    Pharmaceutical Companies given a Final Call to Register till March 31, 2016 by the NPPA

    Written by Geeta Sharma Sharma Published On 2016-03-01T18:03:10+05:30  |  Updated On 1 March 2016 6:03 PM IST


    New Delhi: In response to the requirement expressed by various industry associations, the National Pharmaceuticals Pricing Authority (NPPA) has given an extension to the pharmaceutical companies in the country asking them to register under the Ingredient Pharmaceutical Database Management System (IPDMS) till March 31, 2016.

    According to an NPPA notice issued the date has been extended a second time round after the first date which was February 15, 2016.

    The National Pharmaceuticals Pricing Authority (NPPA) has made clear to all that March 31st , 2016 would be the final submission date for registration and anybody who fails to register on the final call date might lead the NPPA to initiate prosecution proceedings under the provisions of EC Act, 1955 against them. Submission of requisite and mandatory forms under the DPCO, 2013 through IPDMS by March
    31 2016, being a compulsion for all.

    The notice issued to this effect came when the companies did not comply to the NPPA's earlier orders of a similar nature to register and it held a review meeting with the representatives of pharmaceutical associations who asked the body for more time for online submission of information forms mandated under DPCO 2013 through IPDMS.

    Complying to the request of the Pharmaceutical associations for more time the date of submission was further extended with a severe reprimand that failure to submit mandatory data/mandatory returns prescribed under the Drugs (Price Control) Order, 2013 through the IPDMS will attract penal action under the provisions of DPCO, 2013 read with Essential Commodities Act, 1955.

    NPPA also made clear to the Pharma Associations that it may be constrained to initiate prosecution proceedings under the provisions of EC Act, 1955 against companies which fail to register and submit forms called for by it by March 31st, 2016.







    Drugs (Price Control) Order 2013Ingredient Pharmaceutical Database Management SystemIPDMSNational Pharmaceutical Pricing AuthorityNPPAthe National Pharmaceuticals Pricing Authority

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok